Journal of Neuroinflammation, 2022
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses

Pfeuffer S., Rolfes L., Wirth T. et al.

Journal of Clinical Immunology, 2022
Three Adult Cases of STAT1 Gain-of-Function with Chronic Mucocutaneous Candidiasis Treated with JAK Inhibitors

Borgström E., Edvinsson M., Pérez L. et al.

Journal of the American Society of Nephrology, 2022
Blood Transcriptomes of SARS-CoV-2–Infected Kidney Transplant Recipients Associated with Immune Insufficiency Proportionate to Severity

Sun Z., Zhang Z., Banu K. et al.

Neurology Neuroimmunology & Neuroinflammation, 2022
Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis

Thonhoff J., Berry J., Macklin E. et al.

JACC: Heart Failure, 2022
Pathophysiologic Processes and Novel Biomarkers Associated With Congestion in Heart Failure

Pandhi P., ter Maaten J., Anker S. et al.

International Journal of Cancer, 2022
A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression

Tzaridis T., Weller J., Bachurski D. et al.

European Heart Journal, 2022
Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme

Zannad F., Ferreira J., Butler J. et al.

Gut, 2022
Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn’s disease stopping infliximab: when the remission state hides different types of residual disease activity

Pierre N., Huynh-Thu V., Marichal T. et al.

eBioMedicine, 2022
Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma

Rossi N., Lee K., Bermudez M. et al.

Science Advances, 2022
Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods

Katz D., Robbins J., Deng S. et al.

Molecular Psychiatry, 2022
Cerebrospinal fluid proteomic study of two bipolar disorder cohorts

Isgren A., Göteson A., Holmén-Larsson J. et al.

Physiological Reports, 2022
Quantifying the inflammatory secretome of human intermuscular adipose tissue

Kahn D., Macias E., Zarini S. et al.

Scientific Reports, 2022
Association of extracellular vesicle inflammatory proteins and mortality

Noren Hooten N., Torres S., Mode N. et al.

Journal of Clinical Immunology, 2022
SOCS1 Haploinsufficiency Presenting as Severe Enthesitis, Bone Marrow Hypocellularity, and Refractory Thrombocytopenia in a Pediatric Patient with Subsequent Response to JAK Inhibition

Michniacki T., Walkovich K., DeMeyer L. et al.

American Journal of Respiratory Cell and Molecular Biology, 2022
Multiomic Signatures of Chronic Beryllium Disease Bronchoalveolar Lavage Cells Relate to T-Cell Function and Innate Immunity

Li L., Konigsberg I., Bhargava M. et al.

International Journal of Molecular Sciences, 2022
Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery

Beltrami A., De Martino M., Dalla E. et al.

Nature Communications, 2022
ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19

Pietzner M., Chua R., Wheeler E. et al.

Nordic Journal of Psychiatry, 2022
Intercorrelation of physiological seizure parameters and hormonal changes in electroconvulsive therapy

Thörnblom E., Gingnell M., Cunningham J. et al.

Multiple Sclerosis and Related Disorders, 2022
High-intensity resistance training in people with multiple sclerosis experiencing fatigue: A randomised controlled trial

Englund S., Piehl F., Kierkegaard M.

Journal of Molecular and Cellular Cardiology Plus, 2022
Serial measurements of protein and microRNA biomarkers to specify myocardial infarction subtypes

Schulte C., Singh B., Theofilatos K. et al.